| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 1 sell. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | Levin Arthur A | Chief Scientific Officer | Sale+OE | 4,600 | $27.87 | $128,181.30 | -100% | |
| Jun 16, 2020 | Cormorant Asset Management, LP49 | Former 10% Owner | Buy | 300,000 | $18.00 | $5,400,000.00 | +13.5% | |
| Jun 16, 2020 | Rtw Investments, LP63 | 10% Owner | Buy | 950,000 | $18.00 | $17,100,000.00 | +31.2% |